Modulation of T-regulatory cells by small molecules: potential therapy for GvHD
Allogeneic haematopoietic stem cell transplantation (alloHSCT) is often curative for patients suffering from blood cancers. Nonetheless, significant morbidity and mortality are still prevalent. One major complication is graft versus host disease (GvHD) which occurs in 30-70% of patients. In this dis...
Auteur principal: | Leuschner, U |
---|---|
Autres auteurs: | Roberts, D |
Format: | Thèse |
Langue: | English |
Publié: |
2021
|
Documents similaires
-
Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation
par: Mauro Di Ianni, et autres
Publié: (2024-01-01) -
The Role of Bacteria and Pattern Recognition Receptors in GvHD
par: E. Holler, et autres
Publié: (2010-01-01) -
Fibroblastic reticular cells mitigate acute GvHD via MHCII-dependent maintenance of regulatory T cells
par: Haroon Shaikh, et autres
Publié: (2022-11-01) -
Bone marrow GvHD after allogeneic hematopoietic stem cell transplantation
par: Martin eSzyska, et autres
Publié: (2016-03-01) -
Immunometabolic Therapeutic Targets of Graft-versus-Host Disease (GvHD)
par: Kudakwashe Mhandire, et autres
Publié: (2021-10-01)